Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
recent articles
PHILADELPHIA — June 17, 2026 — Proscia® today introduced the Fifth Generation of its Concentriq®[1] platform, helping pathologists focus on high-judgment decisions and enabling scientists to quickly move from early signals to...
Roche: The new VENTANA® PTEN (SP218) RxDx Assay fulfills an unmet medical need by helping clinicians identify patients with PTEN protein loss who may benefit from combination treatment with TRUQAP. In prostate cancer, PTEN...
Leica Biosystems: High-throughput Aperio GT Elite scanner with AI-enabled quality control supports digital and computational pathology workflows VISTA, CA – June 15, 2026 – Leica Biosystems, a Danaher company and a global leader in...
Join Aiforia for a webinar later this month. Pathologist and AI: A Collaboration in Practice Monday, June 29th, 2026 | 4:00 pm CEST | 5:00 pm EEST | 10:00 am EDT Register Now Even the most accurate AI models only fulfill their full...
Aiforia has been selected via a public tender, won by Palex, to provide AI-assisted diagnostic solutions to a regional health service provider in Spain. Aiforia Technologies Plc, Press Release, June 11, 2026 at 9:30 a.m. EEST Aiforia...
ASCO: Now and Then
- Advocacy
- Anatomic Pathology
- Business
- Clinical Laboratories
- Clinical Pathology
- Conferences
- Current Affairs
- Digital Pathology Conferences
- Digital Pathology News
- Education
- Health Technology Collaboration
- Histology
- Humor
- Informatics
- Laboratory Informatics
- Medical Research
- Microscopy
- Molecular Pathology
- Pathology News
- Personal
- Reports
- Science
- Whole slide
In medical school I drove a cab at night to make ends meet. I rented the medallion from a guy for $50 and kept the difference I made. The Army paid me $692 a month stipend on the Health Professions Scholarship and the studio apartment in...
































